Jain Nikunj 4
4 · SANGAMO THERAPEUTICS, INC · Filed Jan 26, 2026
Research Summary
AI-generated summary of this filing
Sangamo (SGMO) Principal Accounting Officer Surrenders 7,721 Shares
What Happened
Nikunj Jain, Principal Accounting Officer of Sangamo Therapeutics (SGMO), surrendered 7,721 shares on January 22, 2026 to satisfy mandatory tax withholding tied to an RSU vesting. The transaction is reported as a disposition (code F) and used the issuer's closing price on 1/22/2026 of $0.3985/share (reported per-share amount $0.40), representing roughly $3,077 remitted to the company. This was a withholding sale to the issuer, not an open-market sale.
Key Details
- Transaction date: January 22, 2026; Form 4 filed January 26, 2026 (timely within the two-business-day rule).
- Shares surrendered: 7,721; per-share price used: $0.3985 (closing price), reported as $0.40; total value ≈ $3,077.
- Net from the vested installment: 11,029 RSU shares vested on Jan 22, 2026; after surrendering 7,721 for taxes, 3,308 of those vested shares remained issued to the reporting person.
- Footnotes: (F1) confirms the shares were surrendered solely for mandatory tax withholding (not a discretionary sale); (F2) details other RSU grants and vesting schedules (1,618 shares from a 2023 grant and 49,726 from a 2025 grant, subject to future vesting and continuous service); (F3) notes the reporting person holds 5,000 shares from the 2020 Employee Stock Purchase Plan.
- Transaction code meaning: F = tax withholding (disposition to issuer).
Context
This is a routine tax-withholding disposition tied to RSU vesting and should not be read as a market-timing sale. Such transactions are administrative: shares are surrendered to the issuer to cover tax obligations rather than sold in the open market.
Insider Transaction Report
- Tax Payment
Common Stock
[F1][F2][F3]2026-01-22$0.40/sh−7,721$3,077→ 242,996 total
Footnotes (3)
- [F1]Represents shares underlying the portion of a restricted stock unit ("RSU") grant that vested on January 22, 2026, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on January 22, 2026 of $0.3985/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the "2018 EIP"). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise.
- [F2]Includes: (a) 11,029 shares from the January 22, 2026 vesting installment of the Reporting Person's January 22, 2024 RSU grant, (b) 1,618 shares subject Reporting Person's February 24, 2023 RSU grant that will vest in successive equal quarterly installments through February 24, 2026 and (c) 49,726 shares subject to Reporting Person's February 25, 2025 RSU grant that will vest as to one-quarter (1/4) of the shares on February 25, 2026, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP.
- [F3]Includes 5,000 shares acquired on November 28, 2025 under the Issuer's 2020 Employee Stock Purchase Plan.